Search

Motherson / Nexans Autoelectric Merger, Article 6(1)(b) Decision

The European Commission issued a Phase 1 decision under Article 6(1)(b) of Council Regulation 139/2004 for the Motherson / Nexans Autoelectric merger (Case M.12340). The Commission declared the concentration compatible with the common market, marking clearance without a full investigation. The merger involves companies operating in C.29.3 - Manufacture of motor vehicle parts and accessories (NACE Rev. 2.1).

In re D.W. — Legal Custody Affirmed to Third Parties

The Ohio Court of Appeals, Ninth Judicial District, affirmed the Summit County Court of Common Pleas Juvenile Division judgment granting legal custody of child D.W. to paternal grandmother and her long-term partner. The appellate court rejected Mother's claim that the trial court's custody determination was against the manifest weight of the evidence. Mother had failed to comply with her case plan objectives, including obtaining substance use and mental health assessments, submitting to drug screens (she consistently tested positive for methamphetamine over six months), and demonstrating the ability to meet the child's basic needs.

Brazil Updates Turmeric Supplement Safety Limits, Labels

ANVISA published Instrução Normativa 438/2026 on April 22, 2026, updating IN 28/2018 for food supplements containing turmeric (Curcuma longa) or curcuminoids, based on post-market monitoring identifying potential liver damage risks. The rule introduces three key changes: mandatory warning labels for pregnant women, nursing mothers, children, and individuals with liver/biliary diseases or gastric ulcers; new curcumin consumption limits calculated as total curcuminoids; and inclusion of tetrahydrocurcuminoids as a permitted ingredient with mixing restrictions.

Dental Assistant and Family Members Sentenced for Illegal Opioid Distribution

Samantha Cook, Alice Deese, and Janice Deese were sentenced by the Maryland Office of the Attorney General for illegally distributing oxycodone to Dr. Andrew T. Fried, a licensed dentist. Cook sold more than $100,000 worth of oxycodone to Dr. Fried over 18 months, obtaining the pills using Medicaid and Medicare benefits of her mother and step-grandmother. Cook received a 10-year suspended sentence with three years of supervised probation, 100 hours of community service, and exclusion from participating as a provider in any state or federal healthcare programs.

Ocean Water Use Warning for Los Angeles County Beaches Due to Elevated Bacteria

The Los Angeles County Department of Public Health issued an ocean water use warning on April 17, 2026, advising the public to avoid swimming, surfing, and playing in ocean waters at five specific beaches due to elevated bacteria levels exceeding state health standards. Affected locations include Pico-Kenter storm drain at Santa Monica Beach, Inner Cabrillo Beach in San Pedro, Mother's Beach in Marina Del Rey, Santa Monica Pier, and Santa Monica Canyon Creek at Will Rogers State Beach. Recent water samples showed bacterial levels that may increase the risk of illness. The public may call the County's beach hotline at 1-800-525-5662 or visit publichealth.lacounty.gov/beach for recorded information and maps of impacted locations.

XVIVO Liver Perfusion Sets Awarded to KCH for £412,930

KCH Interventional Facilities Management LLP awarded a £412,930 contract (excluding VAT) to XVIVO B.V. for liver perfusion sets under a direct award procedure justified by technical uniqueness. The contract runs from 1 May 2026 to 30 April 2027 with a possible 1-year extension option to 30 April 2028. NICE completed a review in 2025 confirming XVIVO as the only supplier capable of facilitating both Normothermic Perfusion and Hypothermic Perfusion through their Liver Assist products.

Phase II Nivolumab Trial for Metastatic Colorectal and Gastric MSI/dMMR Cancers

A Phase II single-center clinical trial (NCT07542262) is registered under NIH ClinicalTrials.gov to evaluate low-dose nivolumab (40 mg) immunotherapy in patients with MSI/dMMR locally advanced colorectal and gastric cancers. The trial plans to enroll patients into subgroups receiving nivolumab alone or combined with FOLFOX chemotherapy as preoperative therapy, with primary endpoints measuring complete tumor pathomorphosis rates (pCR/TRG1) and secondary endpoints assessing safety, disease-free survival, and R0 resection rates.

Anti-CCR5 Agents Block Cancer Metastasis, CytoDyn

The EPO published patent application EP3947431A1 filed by CytoDyn Inc. on April 15, 2026, titled Anti-CCR5 Agents and Methods of Treatment That Block Cancer Metastasis or Enhance Cell Death Induced by DNA Damaging Chemotherapy. The application lists inventors Richard G. Pestell and Scott Kelly and covers anti-CCR5 agents for blocking cancer metastasis or enhancing cell death from DNA-damaging chemotherapy. The designation covers 35 European Patent Convention member states, potentially providing CytoDyn with patent protection across those jurisdictions upon grant.

Governor Spanberger Signs Momnibus Bills to Improve Maternal Healthcare, Support Virginia Mothers

Governor Abigail Spanberger signed the Virginia Momnibus legislative package on April 22, 2026, enacting four bipartisan bills to improve maternal healthcare coverage. The package includes HB1400 expanding maternal mental healthcare screenings, HB1403 directing the Department of Health to develop a Severe Maternal Morbidity reporting system, HB425 authorizing Medicaid reimbursements for remote monitoring of high-risk pregnant women, and HB1353 directing the Commissioner of Health to assess a statewide maternal health safety initiative. The legislation targets Virginia's high maternal mortality rate, particularly for Black women who face elevated risks compared to other demographics.

Ocean Water Warning Issued for LA County Beaches

The Los Angeles County Department of Public Health issued an ocean water use warning on April 20, 2026, for five beach areas where recent water samples showed bacterial levels exceeding state health standards. Affected locations include Topanga Canyon Beach in Malibu, Pico-Kenter storm drain at Santa Monica Beach, Inner Cabrillo Beach in San Pedro, Mother's Beach in Marina Del Rey, and Santa Monica Pier. One beach area, Santa Monica Canyon Creek at Will Rogers State Beach, was cleared after water quality returned to acceptable levels. The public is advised to avoid swimming, surfing, and playing in ocean waters at the affected locations.

Ocean Water Warning Issued for Six LA County Beaches Due to Elevated Bacteria

The Los Angeles County Department of Public Health has issued ocean water use warnings for six beaches due to elevated bacteria levels exceeding state health standards. The affected locations include Ballona Creek at Dockweiler State Beach, Topanga Canyon Beach in Malibu, Pico-Kenter storm drain at Santa Monica Beach, Inner Cabrillo Beach in San Pedro, Mother's Beach in Marina Del Rey, and Santa Monica Pier. Recent water samples showed bacterial levels that may increase the risk of illness for those who swim, surf, or play in these waters.

Low-dose Bevacizumab Plus Adebrelimab Combined With TACE-HAIC for Unresectable HCC

A single-arm Phase 2 clinical trial (NCT07543783) has been registered as of April 22, 2026, enrolling 38 participants with unresectable hepatocellular carcinoma (HCC) to evaluate the efficacy and safety of low-dose bevacizumab (7.5 mg/kg, Q3W) plus adebrelimab (1200 mg, Q3W) combined with transarterial chemoembolization (TACE) followed by hepatic arterial infusion chemotherapy (HAIC) using the FOLFOX regimen as first-line treatment. The study, sponsored by the Third Affiliated Hospital of Sun Yat-sen University, uses Simon's two-stage optimal design (alpha=0.05, power=0.8) with objective response rate (ORR) per RECIST v1.1 as the primary endpoint.

Iparomlimab Tuvonralimab Head Neck Cancer Phase II Trial

This single-arm, open-label Phase II study (NCT07546383) evaluates iparomlimab and tuvonralimab, administered with or without chemotherapy, in patients with recurrent or metastatic head and neck squamous cell carcinoma (R/M HNSCC) who have progressed after at least one prior systemic therapy. The trial includes a safety run-in phase of approximately three patients, followed by assignment to monotherapy (both antibodies at 5 mg/kg on Day 1, every 3 weeks) or combination therapy adding up to six cycles of platinum-based chemotherapy. The primary endpoint is objective response rate per RECIST 1.1, with secondary endpoints including disease control rate, 6-month progression-free survival, 6-month overall survival, and safety profile.

DNA Research on Station Promoting Cancer Therapies, Radiation Repair

NASA astronauts Chris Williams and Sophie Adenot processed DNA Nano Therapeutics-3 experiment samples in the Kibo laboratory module aboard the International Space Station on April 22, 2026, exploring DNA-inspired assembly techniques for manufacturing nano-therapies such as chemotherapy and immunotherapy to kill cancer cells and activate the immune system. The Expedition 74 crew also tested new exercise hardware, virtual reality goggles for vision screening, and continued unpacking cargo from Northrop Grumman's Cygnus XL resupply ship. Samples will be analyzed on the orbital outpost with a spectrophotometer then returned to Earth for further analysis.

Simulation-Based Childbirth Training and Midwives' Outcomes

NIH registered a randomized controlled trial (NCT07543133) evaluating simulation-based childbirth management training on safe motherhood practices and intrinsic motivation among midwives. Participants are randomly assigned to either an intervention group receiving simulation training or a control group receiving no additional training, with outcomes assessed using validated scales.

AU 2024 Chemotherapy Funding Special Arrangement

The National Health (Efficient Funding of Chemotherapy) Special Arrangement 2024 (F2024L00405) establishes the regulatory framework for prescribing, supplying, and funding chemotherapy drugs and related pharmaceutical benefits under Australia's pharmaceutical benefits scheme. The instrument defines authorized prescribers, eligible patients, maximum doses, repeat quantities, and supply rules, and sets out payment arrangements for approved pharmacists, approved medical practitioners, approved hospital authorities, and TGA-licensed compounders. Healthcare providers, including hospitals, pharmacists, and medical practitioners, must comply with the revised prescription circumstances, authority-required procedures, claims processing, and payment rules under this special arrangement.

Pancreatic Resection in Fit Octogenarians With Nonmetastatic Pancreatic Cancer

The NIH registered an observational clinical study (NCT07542782) examining survival outcomes of pancreatic cancer surgery and post-operative chemotherapy in patients aged 80 and older without metastatic disease, using data from a German cancer registry. The study compares patients who underwent surgical tumor resection with curative intent against those who did not, and further examines the role of additional treatment after surgery.

Kangaroo Care RCT, 112 Mothers, Bucak State Hospital

NIH's ClinicalTrials.gov has registered a randomized controlled trial (NCT07543029) at Bucak State Hospital, Turkey, investigating the effects of Kangaroo Mother Care (KMC) on breastfeeding success and maternal role perception in 112 primiparous mothers. Participants will be randomized to KMC intervention or routine care between June 2025 and June 2026.

Bahamas WHO-Certified for Eliminating Mother-to-Child HIV Transmission

The World Health Organization and Pan American Health Organization certified The Bahamas on April 22, 2026 as having eliminated mother-to-child transmission of HIV, making it the latest Caribbean nation to achieve this milestone. The Bahamas joins 12 countries and territories in the Region of the Americas certified for EMTCT, having met WHO's thresholds of less than 2% mother-to-child transmission rate, fewer than 5 new pediatric HIV infections per 1,000 live births, and 95% or higher coverage for antenatal care, HIV testing, and treatment. The achievement reflects sustained political commitment, universal antenatal care regardless of nationality or legal status, integrated laboratory networks, and multi-month dispensing of antiretroviral medicines.

In re Parenting of R.A.A. - Home State Jurisdiction Affirmed

The Montana Supreme Court affirmed the Nineteenth Judicial District Court's dismissal of Father Jonathan Edward Allen's emergency custody petition, holding that Montana lacked home state jurisdiction over R.A.A. because the minor child had not resided in Montana for more than two years before the petition was filed. The Court also declined to overturn the Court of Appeal of The Hague's decision that R.A.A. had become settled in the Netherlands after being wrongfully removed from the United States in August 2023. Mother Petronella Gerline (Van Oosterom) Allen remains the prevailing party.

Matter of S.J.C. - Parental Rights Termination Affirmed

The Montana Supreme Court affirmed the termination of Father J.C.'s parental rights to four children (A.J.C., N.M.C., A.R.C., and S.J.C.), rejecting his argument that the District Court improperly attributed Mother's conduct to him and affirming grounds under §§ 41-3-609(1)(d) and 41-3-609(1)(f), MCA. The Court also upheld the finding that Father failed to complete the court-ordered treatment plan and erred in not considering guardianship in lieu of termination. The decision, Case No. DA 25-0600, was issued on April 21, 2026.

National Health Chemotherapy Funding Amendment

The Australian Department of Health, Disability and Ageing issued Instrument F2026L00404 amending the National Health (Efficient Funding of Chemotherapy) Special Arrangement 2024. This April 2026 update modifies chemotherapy drug schedules and funding arrangements under the National Health Act 1953, affecting reimbursement rates and coverage for cancer treatments.

Walsh v. Walsh - Undue Influence Over Mother's Estate

The Tennessee Court of Appeals affirmed a trial court's finding that both sons exerted undue influence over their aging mother regarding her estate. The court ordered the mother's home to be distributed according to her 1991 will and credited one son with rental income received after her death.

Emend 125mg Shortage, Alternative Treatments Proposed

ANSM published guidance on April 15, 2026 regarding the shortage of Emend 125mg (aprepitant) oral suspension manufactured by MSD. The drug, used in chemotherapy for children and infants aged 6 months to under 12 years, became unavailable at the end of March 2026 due to production problems. ANSM has arranged alternative supplies including Ivemend 150mg imports and authorized pharmacists to dispense magistral preparations without new prescriptions.

Re M (A Child: Costs) - Appeal from Family Court Costs Order

The England and Wales Court of Appeal (Civil Division) has issued a judgment in the case Re M (A Child: Costs). This appeal concerns a costs order made against the appellant father for approximately £39,268.20 in family law proceedings related to his child. The court's decision will determine the final disposition of this costs appeal.